Clinical Trial: A Phase II Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of SR604 Injection in Patients With Von Willebrand Disease

U.S., June 12 -- ClinicalTrials.gov registry received information related to the study (NCT07640893) titled 'A Phase II Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of SR604 Injection in Patients With Von Willebrand Disease' on June 01.

Brief Summary: The purpose of this study is to evaluate the efficacy, safety, pharmacokinetics (PK), and pharmacodynamic (PD) of SR604 in patients with von Willebrand disease.

Study Start Date: Nov. 26, 2025

Study Type: INTERVENTIONAL

Condition: Von Willebrand Disease (VWD)

Intervention: DRUG: SR604

SR604 will be administered as SC injection.

Recruitment Status: RECRUITING

Sponsor: Shanghai RAAS Blood Products Co., Ltd.

Published by HT Digital Content Services with permiss...